检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘维贤[1] 高原侠[1] 林晓萍[1] 管宇[1]
机构地区:[1]中国医科大学第二临床学院口腔科,沈阳110003
出 处:《中国医科大学学报》2000年第5期370-371,共2页Journal of China Medical University
摘 要:目的 :探讨成纤维细胞生长因子受体与血管瘤增生退化的关系。方法 :采用免疫组织化学 SP法及图像分析技术 ,对 40例增生期血管瘤、30例退化期血管瘤组织中的成纤维细胞生长因子 (FGF)受体表达进行了定量分析。结果 :FGF受体以增生期血管瘤含量最多 ;退化期血管瘤单个 FGF受体阳性细胞上所含受体的量多于增生期血管瘤。结论 :增生期血管瘤组织中 FGF的功能活性强于退化期血管瘤 ;FGF与血管瘤的增生退化过程有密切关系。Objective: Our aim was to determine the relationship between the fibroblast growth factor (FGF) receptor count and the different stage of hemangioma. Methods: The immunohistochemical technique and image analysis technique were used. The numbers of FGFR were determined among 40 cases of hemangioma in proliferative stage, 30 of them in involutional stage, 5 of normal tissue. Results: The number of FGFR in proliferative stage was the highest in these three kinds of tissue. The number of FGF receptor of single cell in involutional stage was higher than that in proliferative stage. Conclusion: The activity of FGF in proliferative stage in higher than that in involutional stage. FGF play an important role in the proliferative and involutional procession of hemangioma.
关 键 词:血管瘤 成纤维细胞生长因子受体 增生 退化
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.66